Celltrion HealthCare Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion HealthCare Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
Green Cross Corporation
sales of 1.37 trillion Korean Won [US$1.15 billion]
of which 84%
Samsung Biologics Co Ltd
(701.59 billion Korean Won [US$591.44 million]
of which 100%
was Biological Medicine Production), and
(1.13 trillion Korean Won [US$951.29 million]
of which 87%
was Bio Business Division).
Celltrion HealthCare Co Ltd reported sales of 1.10 trillion Korean Won (US$928.04 million)
December of 2019.
increase of 54.3%
versus 2018, when the company's sales were 713.49 billion Korean Won .